• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Immunol . mRNA-based influenza vaccine expands the B cell response breadth in humans

tetano

Editor, Senior Moderator
Nat Immunol


. 2026 Jun 15.
doi: 10.1038/s41590-026-02569-5. Online ahead of print.
mRNA-based influenza vaccine expands the B cell response breadth in humans

Hanover C Matz[SUP] #[/SUP][SUP] 1 [/SUP], Tae-Geun Yu[SUP] #[/SUP][SUP] 2 [/SUP], Kritika Dixit[SUP] 1 [/SUP], Caroline Kikawa[SUP] 3 [/SUP], Julian Q Zhou[SUP] 1 [/SUP], Garazi Pena Alzua[SUP] 4 5 [/SUP], Lowrey Peyton[SUP] 2 6 [/SUP], Anders Madsen[SUP] 7 8 [/SUP], Fangjie Han[SUP] 1 [/SUP], Ariana Ghez Farrell[SUP] 9 [/SUP], Robert Hoelzl[SUP] 4 [/SUP], Aaron J Schmitz[SUP] 1 [/SUP], Stephen C Horvath[SUP] 1 [/SUP], Hunter K Keplinger[SUP] 1 [/SUP], Benjamin S Strnad[SUP] 10 [/SUP], Mark J Hoegger[SUP] 10 [/SUP], William D Middleton[SUP] 10 [/SUP], Michael K Klebert[SUP] 11 [/SUP], Nina H Lin[SUP] 12 [/SUP], Raffael Nachbagauer[SUP] 12 [/SUP], Florian Krammer[SUP] 4 5 13 14 15 [/SUP], Robert Paris[SUP] 12 [/SUP], Jesse D Bloom[SUP] 16 17 [/SUP], Jackson S Turner[SUP] 1 [/SUP], Rachel M Presti[SUP] 11 18 19 20 [/SUP], Jiwon Lee[SUP] 21 22 23 [/SUP], Ali H Ellebedy[SUP] 24 25 26 [/SUP]


Affiliations
Abstract

Conventional influenza virus vaccines induce antibody responses of limited breadth. Whether mRNA-based influenza virus vaccines can induce a superior germinal center (GC) response in humans remains unclear. Here we assessed B cell responses in an observational study of cohorts of healthy young adults receiving a licensed, split-virion or investigative mRNA-based quadrivalent seasonal influenza virus vaccine over two consecutive seasons. mRNA-based vaccines consistently elicited higher antibody titers and frequencies of memory B cells. In the draining lymph nodes, mRNA vaccination stimulated sustained GC reactions that persisted for at least 26 weeks after vaccination in 5 of 13 participants across the two seasons. Proteomic analysis of serum IgG repertoire showed that mRNA vaccination increased the number of vaccine-elicited serum IgG clonotypes and promoted intraclonal expansion within pre-existing clonotypes. B cell lineage analyses further indicated that expanded serum clonotypes map to GC B cell-associated sub-branches, consistent with ongoing GC-driven evolution underlying intraclonal expansion. This repertoire remodeling was accompanied by increased binding breadth against antigenically divergent influenza viruses. These findings reveal a key role for persistent GC responses in broadening the repertoire of vaccine-induced antibodies.


 
Back
Top